|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.64 USD | -1.87% |
|
+1.87% | +32.30% |
| Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
| Mar. 14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
NeuroPace, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 18.01 million compared to USD 12.79 million a year ago. Net loss was USD 6.2 million compared to USD 11.15 million a year ago.
Basic loss per share from continuing operations was USD 0.23 compared to USD 0.45 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +32.30% | 399M | |
| +7.84% | 218B | |
| +7.35% | 183B | |
| +13.04% | 134B | |
| +26.03% | 106B | |
| -1.33% | 61.12B | |
| +4.81% | 50.89B | |
| +0.30% | 40.3B | |
| +2.78% | 35.53B | |
| +26.14% | 32.05B |
NEUROPACE, INC. 
